![[CASE STUDY] Efficacy and safety of a nasal spray versus placebo in the treatment of early symptoms of common cold in adults](https://www.biofortis.fr/wp-content/uploads/2023/06/Featured-image-website_-case-studies-1-940x675.png)
by Administrateur Biofortis | Jun 2, 2023 | Case studies_Clinical
Case study in Clinical trials Efficacy and safety of a nasal spray versus placebo in the treatment of early symptoms of common cold in adults See all the case studiesGet in touch Key information Main study endpoints – Change from baseline in the relief of nasal...
![[NEWS] ACCELERATE YOUR ASSAYS](https://www.biofortis.fr/wp-content/uploads/2023/05/LUMINEX-1-1080x675.png)
by Administrateur Biofortis | May 24, 2023 | News
In a continuous improvement of our performance and analytical capabilities that’s complements Biofortis Central lab, our expert staff members have worked to implement a new machine: LUMINEX LX-200. LUMINEX LX-200 system is a compact analyser that performs up to...
![[CASE STUDY] Randomized, placebo-controlled, double-blinded study to evaluate the effect of probiotics on gut function in healthy Chinese adults](https://www.biofortis.fr/wp-content/uploads/2023/05/14-940x675.png)
by Administrateur Biofortis | May 15, 2023 | Case studies_Clinical
Case study in Clinical trials Randomized, placebo-controlled, double-blinded study to evaluate the effect of probiotics on gut function in healthy Chinese adults See all the case studiesGet in touch Key information Main study endpoints – Number of Bowel...
![[CASE STUDY] Randomized, placebo-controlled, double-blinded study of the effect of plant extracts on glucose and lipid homeostasis in subjects with dysglycemia](https://www.biofortis.fr/wp-content/uploads/2023/05/13-940x675.png)
by Administrateur Biofortis | May 15, 2023 | Case studies_Clinical
Case study in Clinical trials Randomized, placebo-controlled, double-blinded study of the effect of plant extracts on glucose and lipid homeostasis in subjects with dysglycemia See all the case studiesGet in touch Key information Main study endpoints – Glycemia...
![[CASE STUDY] Safety and suitability of an infant formula in healthy term infants](https://www.biofortis.fr/wp-content/uploads/2023/05/12-940x675.png)
by Administrateur Biofortis | May 15, 2023 | Case studies_Clinical
Case study in Clinical trials Safety and suitability of an infant formula in healthy term infants See all the case studiesGet in touch Key information Main study endpoints Safety: growth parameters, adverse events Population 360 babies Tested product Infant...
